FDA inspection
Anicare Pharmaceuticals Pvt Ltd.: FDA inspection ending Jan 20, 2023
FDA inspection 1195342 · Official Action Indicated (OAI) · Navi Mumbai
Key facts
| Inspection ID | 1195342 |
|---|---|
| Firm | Anicare Pharmaceuticals Pvt Ltd. |
| FEI number | 3007450508 |
| Address | Plot No. A-143 / 5 & 6, Ttc Ind. Area, Khairne M.I.D.C, Thane-Belapur Rd, Behind Midc Fire Station |
| City | Navi Mumbai |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Jan 20, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data